These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3333871)

  • 21. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children in Papua New Guinea. I. Plasmodium falciparum.
    Darlow B; Vrbova H; Gibney S; Jolley D; Stace J; Alpers M
    Am J Trop Med Hyg; 1982 Jan; 31(1):1-9. PubMed ID: 7036764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda.
    Nevill CG; Ochen K; Munafu CG; Bekobita D; Sezi CL
    East Afr Med J; 1995 Jun; 72(6):349-54. PubMed ID: 7498001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of fansidar-resistant Plasmodium falciparum from Tanzania.
    De Geus A; Meuwissen JH; van Rijn A
    Trop Geogr Med; 1982; 34(3):261-3. PubMed ID: 6758245
    [No Abstract]   [Full Text] [Related]  

  • 25. Malaria chemoprophylaxis in travellers to east Africa: a comparative prospective study of chloroquine plus proguanil with chloroquine plus sulfadoxine-pyrimethamine.
    Fogh S; Schapira A; Bygbjerg IC; Jepsen S; Mordhorst CH; Kuijlen K; Ravn P; Rønn A; Gøtzsche PC
    Br Med J (Clin Res Ed); 1988 Mar; 296(6625):820-2. PubMed ID: 3130927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kenyan chloroquin, fansidar and quninine resistant P. Falciparum.
    Turner GD
    Cent Afr J Med; 1984 Jul; 30(7):136-7. PubMed ID: 6386173
    [No Abstract]   [Full Text] [Related]  

  • 27. Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria.
    McIntosh HM
    Cochrane Database Syst Rev; 2001; (4):CD000386. PubMed ID: 11687077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Falciparum malaria resistant to chloroquine and Fansidar: implications for prophylaxis.
    Eyre SJ
    Br Med J (Clin Res Ed); 1984 Feb; 288(6417):644. PubMed ID: 6421416
    [No Abstract]   [Full Text] [Related]  

  • 29. Falciparum malaria resistant to chloroquine and Fansidar.
    Jaatinen M; Kihamia CM; McLarty DG
    Br Med J (Clin Res Ed); 1984 Jan; 288(6410):65. PubMed ID: 6418318
    [No Abstract]   [Full Text] [Related]  

  • 30. Sulfadoxine and pyrimethamine in the treatment of falciparum malaria in Vietnam.
    Ryan BP
    Med J Aust; 1975 Jan; 1(4):101-3. PubMed ID: 1094249
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
    Tall A; Rabarijaona LP; Robert V; Bedja SA; Ariey F; Randrianarivelojosia M
    Acta Trop; 2007 Jun; 102(3):176-81. PubMed ID: 17568549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined chloroquine/Fansidar-resistant falciparum malaria appears in East Africa.
    Hess U; Timmermans PM; Jones M
    Am J Trop Med Hyg; 1983 Mar; 32(2):217-20. PubMed ID: 6340538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
    de Souza JM; Sheth UK; de Oliveira RM; Roulet H; de Souza SD
    Bull World Health Organ; 1985; 63(3):603-9. PubMed ID: 3899397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extension of multiple drug resistant Plasmodium falciparum malaria in Africa: report of a Central African case.
    Belec L; Bouree P; Testa J; Delmont J; Quenum B; Georges AJ
    Biomed Pharmacother; 1989; 43(9):699-702. PubMed ID: 2696567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The epidemiology of drug-resistant malaria.
    Björkman A; Phillips-Howard PA
    Trans R Soc Trop Med Hyg; 1990; 84(2):177-80. PubMed ID: 2202097
    [No Abstract]   [Full Text] [Related]  

  • 36. Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand.
    Hurwitz ES; Johnson D; Campbell CC
    Lancet; 1981 May; 1(8229):1068-70. PubMed ID: 6112445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria.
    McIntosh HM
    Cochrane Database Syst Rev; 2000; (2):CD000386. PubMed ID: 10796538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic efficacy of chloroquine or amodiaquine in combination with sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Papua New Guinea.
    Jayatilaka KD; Taviri J; Kemiki A; Hwaihwanje I; Bulungol P
    P N G Med J; 2003; 46(3-4):125-34. PubMed ID: 16454394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Falciparum malaria resistant to chloroquine and fansidar: implications for prophylaxis.
    Herzog C; Kibbler CC; Ellis CJ; Mtawali CV
    Br Med J (Clin Res Ed); 1983 Oct; 287(6397):947-8. PubMed ID: 6412900
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren.
    Landgraf B; Kollaritsch H; Wiedermann G; Wernsdorfer WH
    Trans R Soc Trop Med Hyg; 1994; 88(4):440-2. PubMed ID: 7570837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.